Non-coding RNAs as therapeutic targets for preventing myocardial ischemia-reperfusion injury

Expert Opinion on Therapeutic Targets

Volumn 22, Issue 3, 2018, Pages 247-261

  Ong, Sang Bing ^a   Katwadi, Khairunnisa ^a   Kwek, Xiu Yi ^a   Ismail, Nur Izzah ^a,b   Chinda, Kroekkiat ^c   Ong, Sang Ging ^d   Hausenloy, Derek J ^a,e,f,g  

^a DUKE NUS MEDICAL SCHOOL   (Singapore)

^b UNIVERSITY OF MALAYA   (Malaysia)

^c NARESUAN UNIVERSITY   (Thailand)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e DEPARTMENT OF CARDIOLOGY   (Singapore)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

acute myocardial infarction; cardioprotection; Ischemia reperfusion injury; ischemic conditioning; long non coding RNA; microRNAs; non coding RNAs

Indexed keywords

ANTAGOMIR; ANTISENSE OLIGONUCLEOTIDE; BIOLOGICAL MARKER; CARVEDILOL; CHOLINE; GAMMA TOCOTRIENOL; HYDROGEN SULFIDE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; ISOFLURANE; LIOTHYRONINE; LONG UNTRANSLATED RNA; LUTEOLIN; MICRORNA; MICRORNA 1; MICRORNA 107; MICRORNA 145; MICRORNA 21; MICRORNA 22; MICRORNA 29; MICRORNA 31; MORPHINE; NITRITE; PIOGLITAZONE; RESVERATROL; ROSIGLITAZONE; SALVIANOLIC ACID B; TANSHINONE IIA; TRICHOSTATIN A; TRIMETAZIDINE; UNTRANSLATED RNA;

ACUTE HEART INFARCTION; CARDIOVASCULAR FUNCTION; CLINICAL OUTCOME; DRUG TARGETING; GENETIC MANIPULATION; HEART DEVELOPMENT; HEART FAILURE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEAT STRESS; HUMAN; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; MYOCARDIAL ISCHEMIA REPERFUSION INJURY; NONHUMAN; PATHOGENESIS; REMOTE ISCHEMIC CONDITIONING; REVIEW; ANIMAL; CARDIAC MUSCLE CELL; COMPLICATION; GENETICS; HEART INFARCTION; MOLECULARLY TARGETED THERAPY; PATHOLOGY;

ANIMALS; HEART FAILURE; HUMANS; MICRORNAS; MOLECULAR TARGETED THERAPY; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; RNA, LONG NONCODING;

EID: 85044520580     PISSN: 14728222     EISSN: 17447631     Source Type: Journal    
DOI: 10.1080/14728222.2018.1439015     Document Type: Review

References (170)

1. Cabrera-Fuentes HA, Aragones J, Bernhagen J, et al. From basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting report from the third international symposium on “New frontiers in cardiovascular research”. Basic Res Cardiol. 2016;111:69.
2. Hausenloy DJ, Garcia-Dorado D, Botker HE, et al. Novel targets and future strategies for acute cardioprotection: position paper of the European society of cardiology working group on cellular biology of the heart. Cardiovasc Res. 2017;113:564–585.
3. Campo G, Pavasini R, Morciano G, et al. Clinical benefit of drugs targeting mitochondrial function as an adjunct to reperfusion in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials. Int J Cardiol. 2017;244:59–66.
4. Campo G, Pavasini R, Morciano G, et al. Data on administration of cyclosporine, nicorandil, metoprolol on reperfusion related outcomes in ST-segment elevation myocardial infarction treated with percutaneous coronary intervention. Data Brief. 2017;14:197–205.
5. Hausenloy DJ, Botker HE, Engstrom T, et al. Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations. Eur Heart J. 2017;38:935–941. ehw145 [pii]. DOI:10.1093/eurheartj/ehw145
6. Zhao Y, Samal E, Srivastava D., Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature. 2005;436:214–220. nature03817 [pii]. DOI:10.1038/nature03817.
7. Care A, Catalucci D, Felicetti F, et al. MicroRNA-133 controls cardiac hypertrophy. Nat Med. 2007;13:613–618. nm1582 [pii]. DOI:10.1038/nm1582.
8. Van RE, Sutherland LB, Liu N, et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A. 2006;103:18255–18260. 0608791103 [pii]. DOI:10.1073/pnas.0608791103
9. Stieger P, Daniel JM, Tholen C, et al. Targeting of extracellular RNA reduces edema formation and infarct size and improves survival after myocardial infarction in mice. J Am Heart Assoc. 2017;6. JAHA.116.004541 [pii]. DOI:10.1161/JAHA.116.004541
10. Yin C, Wang X, Kukreja RC. Endogenous microRNAs induced by heat-shock reduce myocardial infarction following ischemia-reperfusion in mice. FEBS Lett. 2008;582:4137–4142. S0014-5793(08)00922-8 [pii]. DOI:10.1016/j.febslet.2008.11.014.
11. Poller W, Dimmeler S, Heymans S, et al. Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives. Eur Heart J. 2017. 3738809 [pii]. DOI:10.1093/eurheartj/ehx165
12. Bar C, Chatterjee S, Thum T. Long noncoding RNAs in cardiovascular pathology, diagnosis, and therapy. Circulation. 2016;134:1484–1499. CIRCULATIONAHA.116.023686 [pii]. DOI:10.1161/CIRCULATIONAHA.116.023686
13. Van RE, Sutherland LB, Thatcher JE, et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A. 2008;105:13027–13032. 0805038105 [pii]. DOI:10.1073/pnas.0805038105.
14. Hall AR, Burke N, Dongworth RK, et al. Mitochondrial fusion and fission proteins: novel therapeutic targets for combating cardiovascular disease. Br J Pharmacol. 2014;171:1890–1906.
15. Burke N, Hall AR, Hausenloy DJ. OPA1 in cardiovascular health and disease. Curr Drug Targets. 2015;16: 912–920. CDT-EPUB-64308 [pii].
16. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986;74:1124–1136.
17. Marber MS, Latchman DS, Walker JM, et al. Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. Circulation. 1993;88:1264–1272.
18. Kuzuya T, Hoshida S, Yamashita N, et al. Delayed effects of sublethal ischemia on the acquisition of tolerance to ischemia. Circ Res. 1993;72:1293–1299.
19. Hausenloy DJ, Yellon DM. The second window of preconditioning (SWOP) where are we now? Cardiovasc Drugs Ther. 2010.
20. Cheng Y, Zhu P, Yang J, et al. Ischaemic preconditioning-regulated miR-21 protects heart against ischaemia/reperfusion injury via anti-apoptosis through its target PDCD4. Cardiovasc Res. 2010;87:431–439. cvq082 [pii]. DOI:10.1093/cvr/cvq082.
21. Duan X, Ji B, Wang X, et al. Expression of microRNA-1 and microRNA-21 in different protocols of ischemic conditioning in an isolated rat heart model. Cardiology. 2012;122:36–43. 000338149 [pii]. DOI:10.1159/000338149
22. Wang X, Zhu H, Zhang X, et al. Loss of the miR-144/451 cluster impairs ischaemic preconditioning-mediated cardioprotection by targeting Rac-1. Cardiovasc Res. 2012;94:379–390. cvs096 [pii]. DOI:10.1093/cvr/cvs096
23. Varga ZV, Zvara A, Farago N, et al. MicroRNAs associated with ischemia-reperfusion injury and cardioprotection by ischemic pre- and postconditioning: protectomiRs. Am J Physiol Heart Circ Physiol. 2014;307:H216–H227. ajpheart.00812.2013 [pii]. DOI:10.1152/ajpheart.00812.2013
24. Cheng Y, Tan N, Yang J, et al. A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clin Sci (Lond). 2010;119:87–95. CS20090645 [pii]. DOI:10.1042/CS20090645
25. Rane S, He M, Sayed D, et al. Downregulation of miR-199a derepresses hypoxia-inducible factor-1alpha and Sirtuin 1 and recapitulates hypoxia preconditioning in cardiac myocytes. Circ Res. 2009;104:879–886. CIRCRESAHA.108.193102 [pii]. DOI:10.1161/CIRCRESAHA.108.193102
26. Ong SG, Hausenloy DJ. Hypoxia-inducible factor as a therapeutic target for cardioprotection. Pharmacol Ther. 2012;136:69–81. S0163-7258(12)00130-1 [pii]. DOI:10.1016/j.pharmthera.2012.07.005
27. Ong SG, Lee WH, Theodorou L, et al. HIF-1 reduces ischaemia-reperfusion injury in the heart by targeting the mitochondrial permeability transition pore. Cardiovasc Res. 2014;104:24–36. cvu172 [pii]. DOI:10.1093/cvr/cvu172
28. Yin C, Salloum FN, Kukreja RC. A novel role of microRNA in late preconditioning: upregulation of endothelial nitric oxide synthase and heat shock protein 70. Circ Res. 2009;104:572–575. CIRCRESAHA.108.193250 [pii]. DOI:10.1161/CIRCRESAHA.108.193250
29. Rane S, He M, Sayed D, et al. An antagonism between the AKT and beta-adrenergic signaling pathways mediated through their reciprocal effects on miR-199a-5p. Cell Signal. 2010;22:1054–1062. S0898-6568(10)00061-6 [pii]. DOI:10.1016/j.cellsig.2010.02.008
30. Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003;285:H579–H588.
31. Tsang A, Hausenloy DJ, Mocanu MM, et al. Postconditioning: a form of “modified reperfusion” protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway. Circ Res. 2004;95:230–232.
32. Tsang A, Hausenloy DJ, Yellon DM. Myocardial postconditioning: reperfusion injury revisited. Am J Physiol Heart Circ Physiol. 2005;289:H2–H7.
33. Hausenloy DJ. Cardioprotection techniques: preconditioning, postconditioning and remote con-ditioning (basic science). Curr Pharm Des. 2013;19: 4544–4563. CPD-EPUB-20121221-5 [pii].
34. Hausenloy DJ, Yellon DM. Ischaemic conditioning and reperfusion injury. Nat Rev Cardiol. 2016;13:193–209. nrcardio.2016.5 [pii]. DOI:10.1038/nrcardio.2016.5
35. He B, Xiao J, Ren AJ, et al. Role of miR-1 and miR-133a in myocardial ischemic postconditioning. J Biomed Sci. 2011;18:22. 1423-0127-18-22 [pii]. DOI:10.1186/1423-0127-18-22
36. Tu Y, Wan L, Fan Y, et al. Ischemic postconditioning-mediated miRNA-21 protects against cardiac ischemia/reperfusion injury via PTEN/Akt pathway. PLoS One. 2013;8:e75872. PONE-D-13-17169 [pii]. DOI:10.1371/journal.pone.0075872
37. Wan DY, Zhang Z, Yang HH. Cardioprotective effect of miR-214 in myocardial ischemic postconditioning by down-regulation of hypoxia inducible factor 1, alpha subunit inhibitor. Cell Mol Biol (Noisy -Le-Grand). 2015;61:1–6.
38. Baars T, Skyschally A, Klein-Hitpass L, et al. microRNA expression and its potential role in cardioprotection by ischemic postconditioning in pigs. Pflugers Arch. 2014;466:1953–1961.
39. Gao Y, Huang R, Chen R, et al. Ischemic postconditioning altered microRNAs in human valve replacement. J Surg Res. 2016;200:28–35. S0022-4804(15)00751-9 [pii]. DOI:10.1016/j.jss.2015.07.010
40. Bian B, Yu XF, Wang GQ, et al. Role of miRNA-1 in regulating connexin 43 in ischemia-reperfusion heart injury: a rat model. Cardiovasc Pathol. 2017;27:37–42. S1054-8807(16)30255-1 [pii]. DOI:10.1016/j.carpath.2016.12.006
41. Zhu J, Yao K, Wang Q, et al. Ischemic postconditioning-regulated miR-499 protects the rat heart against ischemia/reperfusion injury by inhibiting apoptosis through PDCD4. Cell Physiol Biochem. 2016;39:2364–2380. 000452506 [pii]. DOI:10.1159/000452506
42. Przyklenk K, Bauer B, Ovize M, et al. Regional ischemic ‘preconditioning’ protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation. 1993;87:893–899.
43. Hausenloy DJ, Yellon DM. Remote ischaemic preconditioning: underlying mechanisms and clinical application. Cardiovasc Res. 2008;79:377–386.
44. Pickard JM, Botker HE, Crimi G, et al. Remote ischemic conditioning: from experimental observation to clinical application: report from the 8th biennial hatter cardiovascular institute workshop. Basic Res Cardiol. 2015;110:453.
45. Sivaraman V, Pickard JM, Hausenloy DJ. Remote ischaemic conditioning: cardiac protection from afar. Anaesthesia. 2015;70:732–748.
46. Oxman T, Arad M, Klein R, et al. Limb ischemia preconditions the heart against reperfusion tachyarrhythmia. Am J Physiol. 1997;273:H1707–H1712.
47. Birnbaum Y, Hale SL, Kloner RA. Ischemic preconditioning at a distance: reduction of myocardial infarct size by partial reduction of blood supply combined with rapid stimulation of the gastrocnemius muscle in the rabbit. Circulation. 1997;96:1641–1646.
48. Kharbanda RK, Mortensen UM, White PA, et al. Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation. 2002;106:2881–2883.
49. Candilio L, Hausenloy DJ, Yellon DM. Remote ischemic conditioning: a clinical trial’s update. J Cardiovasc Pharmacol Ther. 2011;16:304–312. 16/3-4/304 [pii]. DOI:10.1177/1074248411411711
50. Candilio L, Malik A, Hausenloy DJ. Protection of organs other than the heart by remote ischemic conditioning. J Cardiovasc Med (Hagerstown). 2013;14:193–205.
51. Hausenloy DJ, Candilio L, Evans R, et al. Remote ischemic preconditioning and outcomes of cardiac surgery. N Engl J Med. 2015;373:1408–1417.
52. White SK, Frohlich GM, Sado DM, et al. Remote ischemic conditioning reduces myocardial infarct size and edema in patients with ST-segment elevation myocardial infarction. JACC Cardiovasc Interv. 2015;8:178–188. S1936-8798(14)01073-5 [pii]. DOI:10.1016/j.jcin.2014.05.015
53. Hausenloy DJ, Iliodromitis EK, Andreadou I, et al. Investigating the signal transduction pathways underlying remote ischemic conditioning in the porcine heart. Cardiovasc Drugs Ther. 2012;26:87–93.
54. Pickard JM, Davidson SM, Hausenloy DJ, et al. Co-dependence of the neural and humoral pathways in the mechanism of remote ischemic conditioning. Basic Res Cardiol. 2016;111:50.
55. Brandenburger T, Grievink H, Heinen N, et al. Effects of remote ischemic preconditioning and myocardial ischemia on microRNA-1 expression in the rat heart in vivo. Shock. 2014;42:234–238.
56. Slagsvold KH, Rognmo O, Hoydal M, et al. Remote ischemic preconditioning preserves mitochondrial function and influences myocardial microRNA expression in atrial myocardium during coronary bypass surgery. Circ Res. 2014;114:851–859. CIRCRESAHA.114.302751 [pii]. DOI:10.1161/CIRCRESAHA.114.302751
57. Hu Q, Luo W, Huang L, et al. Apoptosis-related microRNA changes in the right atrium induced by remote ischemic perconditioning during valve replacement surgery. Sci Rep. 2016;6:18959. srep18959 [pii]. DOI:10.1038/srep18959.
58. Slagsvold KH, Moreira JB, Rognmo O, et al. Remote ischemic preconditioning preserves mitochondrial function and activates pro-survival protein kinase Akt in the left ventricle during cardiac surgery: a randomized trial. Int J Cardiol. 2014;177:409–417. S0167-5273(14)01947-0 [pii]. DOI:10.1016/j.ijcard.2014.09.206
59. Li J, Rohailla S, Gelber N, et al. MicroRNA-144 is a circulating effector of remote ischemic preconditioning. Basic Res Cardiol. 2014;109:423.
60. Giricz Z, Varga ZV, Baranyai T, et al. Cardioprotection by remote ischemic preconditioning of the rat heart is mediated by extracellular vesicles. J Mol Cell Cardiol. 2014;68:75–78. S0022-2828(14)00014-5 [pii]. DOI:10.1016/j.yjmcc.2014.01.004
61. Vicencio JM, Yellon DM, Sivaraman V, et al. Plasma exosomes protect the myocardium from ischemia-reperfusion injury. J Am Coll Cardiol. 2015;65:1525–1536. S0735-1097(15)00619-1 [pii]. DOI:10.1016/j.jacc.2015.02.026
62. Pryds K, Nielsen RR, Hoff CM, et al. Effect of remote ischemic conditioning on myocardial perfusion in patients with suspected ischemic coronary artery disease. J Nucl Cardiol. 2016. DOI:10.1007/s12350-016-0709-7
63. Wei M, Xin P, Li S, et al. Repeated remote ischemic postconditioning protects against adverse left ventricular remodeling and improves survival in a rat model of myocardial infarction. Circ Res. 2011;108:1220–1225. CIRCRESAHA.110.236190 [pii]. DOI:10.1161/CIRCRESAHA.110.236190
64. Yamaguchi T, Izumi Y, Nakamura Y, et al. Repeated remote ischemic conditioning attenuates left ventricular remodeling via exosome-mediated intercellular communication on chronic heart failure after myocardial infarction. Int J Cardiol. 2015;178:239–246. S0167-5273(14)02081-6 [pii]. DOI:10.1016/j.ijcard.2014.10.144
65. Chen Z, Jia S, Li D, et al. Silencing of long noncoding RNA AK139328 attenuates ischemia/reperfusion injury in mouse livers. PLoS One. 2013;8:e80817. PONE-D-13-35181 [pii]. DOI:10.1371/journal.pone.0080817
66. Dharap A, Nakka VP, Vemuganti R. Effect of focal ischemia on long noncoding RNAs. Stroke. 2012;43:2800–2802. STROKEAHA.112.669465 [pii]. DOI:10.1161/STROKEAHA.112.669465
67. Liu Y, Li G, Lu H, et al. Expression profiling and ontology analysis of long noncoding RNAs in post-ischemic heart and their implied roles in ischemia/reperfusion injury. Gene. 2014;543:15–21. S0378-1119(14)00416-8 [pii]. DOI:10.1016/j.gene.2014.04.016
68. Kaikkonen MU, Halonen P, Liu OH, et al. Genome-wide dynamics of nascent noncoding RNA transcription in porcine heart after myocardial infarction. Circ Cardiovasc Genet. 2017;10. CIRCGENETICS.117.001702 [pii]. DOI:10.1161/CIRCGENETICS.117.001702
69. Saddic LA, Sigurdsson MI, Chang TW, et al. The long noncoding RNA landscape of the ischemic human left ventricle. Circ Cardiovasc Genet. 2017;10. CIRCGENETICS.116.001534 [pii]. DOI:10.1161/CIRCGENETICS.116.001534
70. Wang K, Liu F, Cy L, et al. The long noncoding RNA NRF regulates programmed necrosis and myocardial injury during ischemia and reperfusion by targeting miR-873. Cell Death Differ. 2016;23:1394–1405. cdd201628 [pii]. DOI:10.1038/cdd.2016.28
71. Gong L, Xu H, Chang H, et al. Knockdown of long non-coding RNA MEG3 protects H9c2 cells from hypoxia-induced injury by targeting microRNA-183. J Cell Biochem. 2017. DOI:10.1002/jcb.26304
72. Tu G, Zou L, Liu S, et al. Long noncoding NONRATT021972 siRNA normalized abnormal sympathetic activity mediated by the upregulation of P2X7 receptor in superior cervical ganglia after myocardial ischemia. Purinergic Signal. 2016;12:521–535.
73. Zou L, Tu G, Xie W, et al. LncRNA NONRATT021972 involved the pathophysiologic processes mediated by P2X7 receptors in stellate ganglia after myocardial ischemic injury. Purinergic Signal. 2016;12:127–137.
74. Yoon JH, Abdelmohsen K, Gorospe M. Functional interactions among microRNAs and long noncoding RNAs. Semin Cell Dev Biol. 2014;34:9–14. S1084-9521(14)00170-0 [pii]. DOI:10.1016/j.semcdb.2014.05.015
75. Li N, Ponnusamy M, Mp L, et al. The role of MicroRNA and LncRNA-MicroRNA interactions in regulating ischemic heart disease. J Cardiovasc Pharmacol Ther. 2016. 1074248416667600 [pii]. DOI:10.1177/1074248416667600
76. Wang K, Liu CY, Zhou LY, et al. APF lncRNA regulates autophagy and myocardial infarction by targeting miR-188-3p. Nat Commun. 2015;6:6779. ncomms7779 [pii]. DOI:10.1038/ncomms7779
77. Wang K, Long B, Zhou LY, et al. CARL lncRNA inhibits anoxia-induced mitochondrial fission and apoptosis in cardiomyocytes by impairing miR-539-dependent PHB2 downregulation. Nat Commun. 2014;5:3596. ncomms4596 [pii]. DOI:10.1038/ncomms4596
78. Wang K, Sun T, Li N, et al. MDRL lncRNA regulates the processing of miR-484 primary transcript by targeting miR-361. PLoS Genet. 2014;10:e1004467. PGENETICS-D-13-03236 [pii]. DOI:10.1371/journal.pgen.1004467
79. Wang JX, Zhang XJ, Li Q, et al. MicroRNA-103/107 regulate programmed necrosis and myocardial ischemia/reperfusion injury through targeting FADD. Circ Res. 2015;117:352–363. CIRCRESAHA.117.305781 [pii]. DOI:10.1161/CIRCRESAHA.117.305781
80. Perazzolo MM, Lima JA, Iliceto S. MRI in acute myocardial infarction. Eur Heart J. 2011;32:284–293. ehq409 [pii]. DOI:10.1093/eurheartj/ehq409
81. Hausenloy DJ, Bulluck H. Risk stratification by cardiovascular magnetic resonance after reperfused ST-segment elevation myocardial infarction: ready for prime time? JACC Cardiovasc Imaging. 2017. S1936-878X(17)30622-8 [pii]. DOI:10.1016/j.jcmg.2017.05.025
82. Bulluck H, Hammond-Haley M, Weinmann S, et al. Myocardial infarct size by CMR in clinical cardioprotection studies: insights from randomized controlled trials. JACC Cardiovasc Imaging. 2017;10:230–240. S1936-878X(17)30065-7 [pii]. DOI:10.1016/j.jcmg.2017.01.008
83. Xuan L, Sun L, Zhang Y, et al. Circulating long non-coding RNAs NRON and MHRT as novel predictive biomarkers of heart failure. J Cell Mol Med. 2017;21:1803–1814.
84. Xu Y, Huang R, Gu J, et al. Identification of long non-coding RNAs as novel biomarker and potential therapeutic target for atrial fibrillation in old adults. Oncotarget. 2016;7:10803–10811. 7514 [pii]. DOI:10.18632/oncotarget.7514
85. Wang P, Fu H, Cui J, et al. Differential lncRNAmRNA coexpression network analysis revealing the potential regulatory roles of lncRNAs in myocardial infarction. Mol Med Rep. 2016;13:1195–1203.
86. Viereck J, Thum T. Circulating noncoding RNAs as biomarkers of cardiovascular disease and injury. Circ Res. 2017;120:381–399. CIRCRESAHA.116.308434 [pii]. DOI:10.1161/CIRCRESAHA.116.308434
87. Wang GK, Zhu JQ, Zhang JT, et al. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J. 2010;31:659–666. ehq013 [pii]. DOI:10.1093/eurheartj/ehq013
88. Ai J, Zhang R, Li Y, et al. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun. 2010;391:73–77. S0006-291X(09)02161-5 [pii]. DOI:10.1016/j.bbrc.2009.11.005
89. D’Alessandra Y, Devanna P, Limana F, et al. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J. 2010;31:2765–2773. ehq167 [pii]. DOI:10.1093/eurheartj/ehq167
90. Gidlof O, Andersson P, Van Der Pals J, et al. Cardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination, and can be detected in urine samples. Cardiology. 2011;118:217–226. 000328869 [pii]. DOI:10.1159/000328869
91. Widera C, Gupta SK, Lorenzen JM, et al. Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. J Mol Cell Cardiol. 2011;51:872–875. S0022-2828(11)00276-8 [pii]. DOI:10.1016/j.yjmcc.2011.07.011
92. Lv P, Zhou M, He J, et al. Circulating miR-208b and miR-34a are associated with left ventricular remodeling after acute myocardial infarction. Int J Mol Sci. 2014;15:5774–5788. ijms15045774 [pii]. DOI:10.3390/ijms15045774
93. Peng L, Chun-Guang Q, Bei-Fang L, et al. Clinical impact of circulating miR-133, miR-1291 and miR-663b in plasma of patients with acute myocardial infarction. Diagn Pathol. 2014;9:89. 1746-1596-9-89 [pii]. DOI:10.1186/1746-1596-9-89
94. Zhang R, Lan C, Pei H, et al. Expression of circulating miR-486 and miR-150 in patients with acute myocardial infarction. BMC Cardiovasc Disord. 2015;15:51.
95. Zampetaki A, Willeit P, Tilling L, et al. Prospective study on circulating microRNAs and risk of myocardial infarction. J Am Coll Cardiol. 2012;60:290–299. S0735-1097(12)01588-4 [pii]. DOI:10.1016/j.jacc.2012.03.056
96. He F, Lv P, Zhao X, et al. Predictive value of circulating miR-328 and miR-134 for acute myocardial infarction. Mol Cell Biochem. 2014;394:137–144.
97. Devaux Y, Vausort M, McCann GP, et al. A panel of 4 microRNAs facilitates the prediction of left ventricular contractility after acute myocardial infarction. PLoS One. 2013;8:e70644. PONE-D-13-16789 [pii]. DOI:10.1371/journal.pone.0070644
98. Schulte C, Molz S, Appelbaum S, et al. miRNA-197 and miRNA-223 predict cardiovascular death in a cohort of patients with symptomatic coronary artery disease. PLoS One. 2015;10:e0145930. PONE-D-15-36143 [pii]. DOI:10.1371/journal.pone.0145930
99. Matsumoto S, Sakata Y, Nakatani D, et al. A subset of circulating microRNAs are predictive for cardiac death after discharge for acute myocardial infarction. Biochem Biophys Res Commun. 2012;427:280–284. S0006-291X(12)01779-2 [pii]. DOI:10.1016/j.bbrc.2012.09.039
100. Matsumoto S, Sakata Y, Suna S, et al. Circulating p53-responsive microRNAs are predictive indicators of heart failure after acute myocardial infarction. Circ Res. 2013;113:322–326. CIRCRESAHA.113.301209 [pii]. DOI:10.1161/CIRCRESAHA.113.301209
101. Vausort M, Wagner DR, Devaux Y. Long noncoding RNAs in patients with acute myocardial infarction. Circ Res. 2014;115:668–677. CIRCRESAHA.115.303836 [pii]. DOI:10.1161/CIRCRESAHA.115.303836.
102. Li X, Dai Y, Yan S, et al. Down-regulation of lncRNA KCNQ1OT1 protects against myocardial ischemia/reperfusion injury following acute myocardial infarction. Biochem Biophys Res Commun. 2017. S0006-291X(17)31541-3 [pii]. DOI:10.1016/j.bbrc.2017.08.005
103. Yan Y, Zhang B, Liu N, et al. Circulating long noncoding RNA UCA1 as a novel biomarker of acute myocardial infarction. Biomed Res Int. 2016;2016:8079372.
104. Zhang Y, Sun L, Xuan L, et al. Reciprocal changes of circulating long non-coding RNAs ZFAS1 and CDR1AS predict acute myocardial infarction. Sci Rep. 2016;6:22384. srep22384 [pii]. DOI:10.1038/srep22384
105. Zhang J, Gao C, Meng M, et al. Long Noncoding RNA MHRT Protects Cardiomyocytes against H2O2-Induced Apoptosis. Biomol Ther (Seoul). 2016;24:19–24. bt-24-019 [pii]. DOI:10.4062/biomolther.2015.066
106. Ong SB, Lu S, Katwadi K, et al. Nanoparticle delivery of mitoprotective agents to target ischemic heart disease. Future Cardiol. 2017;13: 195–198. 10.2217/fca-2017-0012.
107. Arslan F, Lai RC, Smeets MB, et al. Mesenchymal stem cell-derived exosomes increase ATP levels, decrease oxidative stress and activate PI3K/Akt pathway to enhance myocardial viability and prevent adverse remodeling after myocardial ischemia/reperfusion injury. Stem Cell Res. 2013;10:301–312. S1873-5061(13)00003-2 [pii]. DOI:10.1016/j.scr.2013.01.002
108. Lai RC, Arslan F, Lee MM, et al. Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury. Stem Cell Res. 2010;4:214–222. S1873-5061(09)00141-X [pii]. DOI:10.1016/j.scr.2009.12.003
109. Wang Y, Zhang L, Li Y, et al. Exosomes/microvesicles from induced pluripotent stem cells deliver cardioprotective miRNAs and prevent cardiomyocyte apoptosis in the ischemic myocardium. Int J Cardiol. 2015;192:61–69. S0167-5273(15)01039-6 [pii]. DOI:10.1016/j.ijcard.2015.05.020
110. Zhang J, Ma J, Long K, et al. Overexpression of exosomal cardioprotective miRNAs mitigates hypoxia-induced H9c2 cells apoptosis. Int J Mol Sci. 2017;18. ijms18040711 [pii]. DOI:10.3390/ijms18040711
111. De CG, Gallet R, Cambier L, et al. Exosomal MicroRNA transfer into macrophages mediates cellular postconditioning. Circulation. 2017;136:200–214. CIRCULATIONAHA.116.024590 [pii]. DOI:10.1161/CIRCULATIONAHA.116.024590
112. Lee SY, Lee S, Choi E, et al. Small molecule-mediated up-regulation of microRNA targeting a key cell death modulator BNIP3 improves cardiac function following ischemic injury. Sci Rep. 2016;6:23472. srep23472 [pii]. DOI:10.1038/srep23472
113. Tang Y, Zheng J, Sun Y, et al. MicroRNA-1 regulates cardiomyocyteapoptosis by targeting Bcl-2. Int Heart J. 2009;50:377–387. JST. 775JSTAGE/ihj/50.377 [pii].
114. Pan Z, Sun X, Ren J, et al. miR-1 exacerbates cardiac ischemiareperfusioninjury in mouse models. PLoS One. 2012;7:e50515. PONE-D-12-13388 [pii]. DOI:10.1371/journal.pone.0050515
115. Bostjancic E, Zidar N, Stajer D, et al. MicroRNAs miR-1, miR-133a, 780 miR-133b and miR-208 are dysregulated in human myocardial infarction. Cardiology. 2010;115:163–169. 000268088 [pii]. DOI:10.1159/000268088
116. Chaudhuri AD, Choi DC, Kabaria S, et al. MicroRNA-7 regulates the function of mitochondrial permeability transition pore by targeting 785 VDAC1 expression. J Biol Chem. 2016;291:6483–6493. M115.691352 [pii]. DOI:10.1074/jbc.M115.691352
117. Hullinger TG, Montgomery RL, Seto AG, et al. Inhibition of miR-15 protects against cardiac ischemic injury. Circ Res. 2012;110:71–81. CIRCRESAHA.111.244442 [pii]. DOI:10.1161/CIRCRESAHA.111.244442
118. Dong S, Cheng Y, Yang J, et al. MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J Biol Chem. 2009;284:29514–29525. M109.027896 [pii]. DOI:10.1074/jbc.M109.027896
119. Sayed D, He M, Hong C, et al. MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of Fas ligand. J Biol Chem. 2010;285:20281–20290. M110.109207 [pii]. DOI:10.1074/jbc.M110.109207
120. Qin Y, Yu Y, Dong H, et al. MicroRNA 21 inhibits left ventricular remodeling in the early phase of rat model with ischemia-reperfusion injury by suppressing cell apoptosis. Int J Med Sci. 2012;9:413–423. ijmsv09p0413 [pii]. DOI:10.7150/ijms.4514
121. Chen Z, Qi Y, Gao C. Cardiac myocyte-protective effect of microRNA-22 during ischemia and reperfusion through disrupting the caveolin-3/eNOS signaling. Int J Clin Exp Pathol. 2015;8:4614–4626.
122. Yang J, Chen L, Yang J, et al. MicroRNA-22 targeting CBP protects against myocardial ischemia-reperfusion injury through anti-apoptosis in rats. Mol Biol Rep. 2014;41:555–561.
123. Qian L, Van Laake LW, Huang Y, et al. miR-24 inhibits apoptosis and represses Bim in mouse cardiomyocytes. J Exp Med. 2011;208:549–560. jem.20101547 [pii]. DOI:10.1084/jem.20101547
124. Wang Y, Men M, Yang W, et al. MiR-31 downregulation protects against cardiac ischemia/reperfusion injury by targeting protein kinase C epsilon (PKCepsilon) directly. Cell Physiol Biochem. 2015;36:179–190. 000374062 [pii]. DOI:10.1159/000374062
125. Hinkel R, Penzkofer D, Zuhlke S, et al. Inhibition of microRNA-92a protects against ischemia/reperfusion injury in a large-animal model. Circulation. 2013;128:1066–1075. CIRCULATIONAHA.113.001904 [pii]. DOI:10.1161/CIRCULATIONAHA.113.001904
126. Zeng XC, Li L, Wen H, et al. MicroRNA-128 inhibition attenuates myocardial ischemia/reperfusion injury-induced cardiomyocyte apoptosis by the targeted activation of peroxisome proliferator-activated receptor gamma. Mol Med Rep. 2016;14:129–136.
127. Li S, Xiao FY, Shan PR, et al. Overexpression of microRNA-133a inhibits ischemia-reperfusion-induced cardiomyocyte apoptosis by targeting DAPK2. J Hum Genet. 2015;60:709–716. jhg201596 [pii]. DOI:10.1038/jhg.2015.96
128. Li J, Li Y, Jiao J, et al. Mitofusin 1 is negatively regulated by microRNA 140 in cardiomyocyte apoptosis. Mol Cell Biol. 2014;34:1788–1799. MCB.00774-13 [pii]. DOI:10.1128/MCB.00774-13
129. Wang Y, Ouyang M, Wang Q, et al. MicroRNA-142-3p inhibits hypoxia/reoxygenationinduced apoptosis and fibrosis of cardiomyocytes by targeting high mobility group box 1. Int J Mol Med. 2016;38:1377–1386.
130. Zhang X, Wang X, Zhu H, et al. Synergistic effects of the GATA-4-mediated miR-144/451 cluster in protection against simulated ischemia/reperfusion-induced cardiomyocyte death. J Mol Cell Cardiol. 2010;49:841–850. S0022-2828(10)00294-4 [pii]. DOI:10.1016/j.yjmcc.2010.08.007
131. Li R, Yan G, Li Q, et al. MicroRNA-145 protects cardiomyocytes against hydrogen peroxide (H(2)O(2))-induced apoptosis through targeting the mitochondria apoptotic pathway. PLoS One. 2012;7:e44907. PONE-D-12-11469 [pii]. DOI:10.1371/journal.pone.0044907
132. Wang X, Ha T, Liu L, et al. Increased expression of microRNA-146a decreases myocardial ischaemia/reperfusion injury. Cardiovasc Res. 2013;97:432–442. cvs356 [pii]. DOI:10.1093/cvr/cvs356
133. Das S, Kohr M, Dunkerly-Eyring B, et al. Divergent effects of miR-181 family members on myocardial function through protective cytosolic and detrimental mitochondrial microRNA targets. J Am Heart Assoc. 2017;6. JAHA.116.004694 [pii]. DOI:10.1161/JAHA.116.004694
134. Zhang Y, Huang R, Zhou W, et al. miR-192-5p mediates hypoxia/ reoxygenation-induced apoptosis in H9c2 cardiomyocytes via tar-geting of FABP3. J Biochem Mol Toxicol. 2017;31. DOI:10.1002/jbt.21873
135. Hang P, Sun C, Guo J, et al. BDNF-mediates down-regulation of microRNA-195 inhibits ischemic cardiac apoptosis in rats. Int J Biol Sci. 2016;12:979–989. ijbsv12p0979 [pii]. DOI:10.7150/ijbs.15071
136. Chen Z, Zhang S, Guo C, et al. Downregulation of miR-200c protects cardiomyocytes from hypoxia-induced apoptosis by targeting GATA-4. Int J Mol Med. 2017;39:1589–1596.
137. Aurora AB, Mahmoud AI, Luo X, et al. MicroRNA-214 protects the mouse heart from ischemic injury by controlling Ca(2)(+) overload and cell death. J Clin Invest. 2012;122:1222–1232. 59327 [pii]. DOI:10.1172/JCI59327
138. Qin D, Wang X, Li Y, et al. MicroRNA-223-5p and −3p cooperatively suppress necroptosis in ischemic/reperfused hearts. J Biol Chem. 2016;291:20247–20259. M116.732735 [pii]. DOI:10.1074/jbc.M116.732735
139. Ren XP, Wu J, Wang X, et al. MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation. 2009;119:2357–2366.
140. Meng X, Ji Y, Wan Z, et al. Inhibition of miR-363 protects cardiomyocytes against hypoxia-induced apoptosis through regulation of Notch signaling. Biomed Pharmacother. 2017;90:509–516. S0753-3322(16)32624-5 [pii]. DOI:10.1016/j.biopha.2017.03.080
141. Fang J, Song XW, Tian J, et al. Overexpression of microRNA-378 attenuates ischemia-induced apoptosis by inhibiting caspase-3 expression in cardiac myocytes. Apoptosis. 2012;17:410–423.
142. Xu H, Jin L, Chen Y, et al. Downregulation of microRNA-429 protects cardiomyocytes against hypoxia-induced apoptosis by increasing Notch1 expression. Int J Mol Med. 2016;37:1677–1685.
143. Xie J, Hu X, Yi C, et al. MicroRNA451 protects against cardiomyocyte anoxia/reoxygenation injury by inhibiting high mobility group box 1 expression. Mol Med Rep. 2016;13:5335–5341.
144. Wang X, Zhang X, Ren XP, et al. MicroRNA-494 targeting both proapoptotic and antiapoptotic proteins protects against ischemia/reperfusion-induced cardiac injury. Circulation. 2010;122:1308–1318. CIRCULATIONAHA.110.964684 [pii]. DOI:10.1161/CIRCULATIONAHA.110.964684
145. Wang JX, Jiao JQ, Li Q, et al. miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat Med. 2011;17:71–78. nm.2282 [pii]. DOI:10.1038/nm.2282
146. Wu Z, Qi Y, Guo Z, et al. miR-613 suppresses ischemia-reperfusion-induced cardiomyocyte apoptosis by targeting the programmed cell death 10 gene. Biosci Trends. 2016;10:251–257.
147. Long B, Wang K, Li N, et al. miR-761 regulates the mitochondrial network by targeting mitochondrial fission factor. Free Radic Biol Med. 2013;65:371–379. S0891-5849(13)00340-7 [pii]. DOI:10.1016/j.freeradbiomed.2013.07.009
148. Wang K, Long B, Li N, et al. MicroRNA-2861 regulates programmed necrosis in cardiomyocyte by impairing adenine nucleotide translocase 1 expression. Free Radic Biol Med. 2016;91:58–67. S0891-5849(15)01140-5 [pii]. DOI:10.1016/j.freeradbiomed.2015.11.031
149. Lu Y, Zhang Y, Shan H, et al. MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection. Cardiovasc Res. 2009;84:434–441. cvp232 [pii]. DOI:10.1093/cvr/cvp232
150. Park KM, Teoh JP, Wang Y, et al. Carvedilol-responsive microRNAs, miR-199a-3p and −214 protect cardiomyocytes from simulated ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2016;311:H371–H383. ajpheart.00807.2015 [pii]. DOI:10.1152/ajpheart.00807.2015
151. Shan H, Li X, Pan Z, et al. Tanshinone IIA protects against sudden cardiac death induced by lethal arrhythmias via repression of microRNA-1. Br J Pharmacol. 2009;158:1227–1235. BPH377 [pii]. DOI:10.1111/j.1476-5381.2009.00377.x
152. Zhang Y, Zhang L, Chu W, et al. Tanshinone IIA inhibits miR-1 expression through p38 MAPK signal pathway in post-infarction rat cardiomyocytes. Cell Physiol Biochem. 2010;26:991–998. 000324012 [pii]. DOI:10.1159/000324012
153. Ye Y, Hu Z, Lin Y, et al. Downregulation of microRNA-29 by antisense inhibitors and a PPAR-gamma agonist protects against myocardial ischaemia-reperfusion injury. Cardiovasc Res. 2010;87:535–544. cvq053 [pii]. DOI:10.1093/cvr/cvq053
154. Mukhopadhyay P, Mukherjee S, Ahsan K, et al. Restoration of altered microRNA expression in the ischemic heart with resveratrol. PLoS One. 2010;5:e15705.
155. Mukhopadhyay P, Das S, Ahsan MK, et al. Modulation of microRNA 20b with resveratrol and longevinex is linked with their potent anti-angiogenic action in the ischaemic myocardium and synergestic effects of resveratrol and gamma-tocotrienol. J Cell Mol Med. 2012;16:2504–2517.
156. Li DF, Tian J, Guo X, et al. Induction of microRNA-24 by HIF-1 protects against ischemic injury in rat cardiomyocytes. Physiol Res. 2012;61: 555–565. 932270 [pii].
157. Shi H, Chen L, Wang H, et al. Synergistic induction of miR-126 by hypoxia and HDAC inhibitors in cardiac myocytes. Biochem Biophys Res Commun. 2013;430:827–832. S0006-291X(12)02236-X [pii]. DOI:10.1016/j.bbrc.2012.11.061
158. Forini F, Kusmic C, Nicolini G, et al. Triiodothyronine prevents cardiac ischemia/reperfusion mitochondrial impairment and cell loss by regulating miR30a/p53 axis. Endocrinology. 2014;155:4581–4590.
159. Kang B, Hong J, Xiao J, et al. Involvement of miR-1 in the protective effect of hydrogen sulfide against cardiomyocyte apoptosis induced by ischemia/reperfusion. Mol Biol Rep. 2014;41:6845–6853.
160. Kang B, Li W, Xi W, et al. Hydrogen sulfide protects cardiomyocytes against apoptosis in ischemia/reperfusion through MiR-1-regulated histone deacetylase 4 pathway. Cell Physiol Biochem. 2017;41:10–21. 000455816 [pii]. DOI:10.1159/000455816
161. Toldo S, Das A, Mezzaroma E, et al. Induction of microRNA-21 with exogenous hydrogen sulfide attenuates myocardial ischemic and inflammatory injury in mice. Circ Cardiovasc Genet. 2014;7:311–320. CIRCGENETICS.113.000381 [pii]. DOI:10.1161/CIRCGENETICS.113.000381
162. Bian C, Xu T, Zhu H, et al. Luteolin inhibits ischemia/reperfusion-induced myocardial injury in rats via downregulation of microRNA-208b-3p. PLoS One. 2015;10:e0144877. PONE-D-15-26956 [pii]. DOI:10.1371/journal.pone.0144877
163. Olson JM, Yan Y, Bai X, et al. Up-regulation of microRNA-21 mediates isoflurane-induced protection of cardiomyocytes. Anesthesiology. 2015;122:795–805.
164. Qiao S, Olson JM, Paterson M, et al. MicroRNA-21 mediates isoflurane-induced cardioprotection against ischemia-reperfusion injury via akt/nitric oxide synthase/mitochondrial permeability transition pore pathway. Anesthesiology. 2015;123:786–798.
165. Yang Q, Yang K, Li AY. Trimetazidine protects against hypoxia-reperfusion-induced cardiomyocyte apoptosis by increasing microRNA-21 expression. Int J Clin Exp Pathol. 2015;8:3735–3741.
166. Ma N, Bai J, Zhang W, et al. Trimetazidine protects against cardiac ischemia/reperfusion injury via effects on cardiac miRNA21 expression, Akt and the Bcl2/Bax pathway. Mol Med Rep. 2016;14:4216–4222.
167. Han Q, Zhang HY, Zhong BL, et al. Antiapoptotic effect of recombinant HMGB1 A-box protein via regulation of microRNA-21 in myocardial ischemia-reperfusion injury model in rats. DNA Cell Biol. 2016;35:192–202.
168. He SF, Zhu HJ, Han ZY, et al. MicroRNA-133b-5p is involved in cardioprotection of morphine preconditioning in rat cardiomyocytes by targeting fas. Can J Cardiol. 2016;32:996–1007. S0828-282X(15)01544-5 [pii]. DOI:10.1016/j.cjca.2015.10.019
169. Li D, Wang J, Hou J, et al. Salvianolic acid B induced upregulation of miR-30a protects cardiac myocytes from ischemia/reperfusion injury. BMC Complement Altern Med. 2016;16:336.
170. Hendgen-Cotta UB, Messiha D, Esfeld S, et al. Inorganic nitrite modulates miRNA signatures in acute myocardial in vivo ischemia/reperfusion. Free Radic Res. 2017;51:91–102.